Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apical Patency and Corticosteroids in Pulpitis
NCT06457828Recruiting
- Sponsor
- Suez Canal University
- Start
- Feb 2021
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexamethasone in irreversible pulpitis (2 arms), sponsored by Suez Canal University. Primary endpoints: Post-operative pain at 7 days and Inflammatory markers at 7 days. Started Feb 2021; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06457828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06457828.